Related Experiment Videos
Propofol does not inhibit hypoxic pulmonary vasoconstriction in humans
L Van Keer1, H Van Aken, E Vandermeersch
1Department of Anesthesiology, University Hospitals, Katholieke Universiteit Leuven, Belgium.
Journal of Clinical Anesthesia
|January 1, 1989
Summary
Propofol, at doses up to 12 mg/kg/h, did not inhibit hypoxic pulmonary vasoconstriction during one-lung ventilation in thoracic surgery patients. This anesthetic agent maintained the essential reflex for managing blood flow to the lungs.
Area of Science:
- Anesthesiology
- Cardiopulmonary Physiology
- Thoracic Surgery
Background:
- Hypoxic pulmonary vasoconstriction (HPV) is a critical mechanism regulating blood flow distribution in the lungs during ventilation changes.
- One-lung ventilation (OLV) is common in thoracic surgery, potentially impairing gas exchange.
- The effects of propofol on HPV during OLV require clarification.
Purpose of the Study:
- To investigate the influence of increasing doses of propofol on HPV.
- To assess the impact of propofol on respiratory and circulatory variables during OLV.
Main Methods:
- A continuous infusion of propofol (6-12 mg/kg/h) was administered to 10 patients undergoing thoracic surgery with OLV.
- Respiratory and circulatory parameters, including PaO2 and systemic vascular resistance, were monitored.
- The HPV reflex was assessed by observing pulmonary vascular responses during OLV with and without propofol.
Main Results:
- Propofol infusion did not alter venous admixture or PaO2.
- Systemic vascular resistance transiently decreased but returned to baseline.
- The HPV reflex remained intact throughout propofol administration at the tested doses.
Conclusions:
- Propofol, at infusion rates of 6-12 mg/kg/h, does not abolish the HPV reflex in patients undergoing OLV.
- Anesthesia with propofol during OLV appears safe regarding HPV and gas exchange.
- Further research may explore lower propofol doses or alternative anesthetic agents for HPV preservation.